跳至主要内容
临床试验/KCT0001952
KCT0001952招募中未知

Efficacy and Safety of Gamiguibi-tang on Sleep Disturbance of Cancer Patients: a Prospective, Randomized, Wait-list Controlled, Pilot Study

Comprehensive & Integrative Medicine Institute0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • 1) over 18.
  • 2) confirmed malignancy by biopsy or radioimage.
  • 3) more than 6 score of Pittsburgh Sleep Quality Index-Korean validation (PSQI-K)
  • 4) more than 2 months of life expectancy
  • 5) cancer or cancer related treatment induced or worsened sleep disturbance.
  • 6) ECOG 0-2
  • 7) sleep disorder lasted for more than recent 1 month.

排除标准

  • 1) to administrate other korean medicine medications for sleep disorder before the study.
  • 2) having change in hypnotics or psychotropic drugs within 2 weaks before the study.
  • 3) =2×UNL of AST or ALT.
  • 4) sleep apnea or mental illness
  • 5) not consent to the trial protocol
  • 6) women of pregnant, on lactating, or having plan of pregnancy while the process of the trial.
  • 7) expected failed compliance due to any other reasons.

研究者

发起方
Comprehensive & Integrative Medicine Institute

相似试验